EP3229921A1 - Hair treatment products containing a methionyl methionine and an oligopeptide with a glu-glu-glu sequence - Google Patents

Hair treatment products containing a methionyl methionine and an oligopeptide with a glu-glu-glu sequence

Info

Publication number
EP3229921A1
EP3229921A1 EP15805476.7A EP15805476A EP3229921A1 EP 3229921 A1 EP3229921 A1 EP 3229921A1 EP 15805476 A EP15805476 A EP 15805476A EP 3229921 A1 EP3229921 A1 EP 3229921A1
Authority
EP
European Patent Office
Prior art keywords
glu
hair
hair treatment
free
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP15805476.7A
Other languages
German (de)
French (fr)
Inventor
Volker Scheunemann
Erik Schulze Zur Wiesche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evonik Operations GmbH
Original Assignee
Evonik Degussa GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Degussa GmbH filed Critical Evonik Degussa GmbH
Publication of EP3229921A1 publication Critical patent/EP3229921A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/12Preparations containing hair conditioners
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/002Preparations for repairing the hair, e.g. hair cure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair

Definitions

  • the invention relates to hair treatment compositions, in particular shampoos and so-called conditioners, with a combination of active ingredients for gentle and effective care of the hair.
  • the hair is treated with special active ingredients, for example quaternary ammonium salts or special polymers, usually in the form of a rinse.
  • special active ingredients for example quaternary ammonium salts or special polymers, usually in the form of a rinse.
  • this treatment improves the combability, the hold and the fullness of the hair and reduces the split rate.
  • multifunctional cosmetic products are known in the prior art.
  • these include the so-called “2 in 1" shampoos, which not only cleanse the hair, but also condition it.
  • These products are highly appreciated by the consumer because of their product performance, at least one process step, for example, conditioning with a classical hair conditioner; unnecessary.
  • oligopeptides for the care of keratinic fibers is known, for example, from WO 2010/026010 A1.
  • oligopeptides with the sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu are disclosed as being particularly suitable for hair care.
  • a first object of the present invention are hair treatment compositions containing - each based on their weight - a) 0.00001 to 20 wt .-% of at least one oligopeptide, the at least one amino acid sequence Glu-Glu-Glu
  • amino group may be free or protonated and the carboxy groups may be free or deprotonated, and
  • the parenthetized hydrogen atom of the amino group, as well as the parenthetical group of the acid function means that the groups concerned may be present as such (then an oligopeptide having the relevant number of amino acids as shown) Formula are three amino acids) or that the amino acid sequence is present in an oligopeptide, which still contains other amino acids - depending on where the other amino acid (s) is / are bound, the parent compound of the above formula by replaced the other amino acid residue (s).
  • Hair treatment compositions for the purposes of the present invention are, for example, hair shampoos, hair conditioners, conditioning shampoos, hairsprays, hair conditioners, hair conditioners, hair wraps, hair tonics, perming solutions, hair dye shampoos, hair dyes, hair fixatives, hair dressings, hairstyling preparations, hair lotions, mousses, hair gels , Hair waxes or their combinations.
  • Preferred agents are therefore shampoos, conditioners or hair tonics.
  • the hair treatment compositions contain - based on their weight - 0.00001 to 20 wt .-% at least an oligopeptide having at least one amino acid sequence Glu-Glu-Glu, that is at least three consecutive glutamic acids.
  • Oligopeptides in the sense of the present application are acid amide-like linked by peptide bonds condensation products of amino acids comprising at least 3 and a maximum of 25 amino acids.
  • the oligopeptide comprises 5 to 15 amino acids, preferably 6 to 13 amino acids, more preferably 7 to 12 amino acids and especially 8, 9 or 10 amino acids.
  • the molecular weight of the oligopeptide contained in the hair treatment agents may vary.
  • Preferred hair treatment compositions are characterized in that the oligopeptide has a molecular weight of from 650 to 3000 Da, preferably from 750 to 2500 Da, particularly preferably from 850 to 2000 Da and in particular from 1000 to 1600 Da.
  • preferred hair treatment compositions are characterized in that the oligopeptide used comprises 5 to 15 amino acids, preferably 6 to 13 amino acids, more preferably 7 to 12 amino acids and especially 8, 9 or 10 amino acids and a molecular weight of 650 to 3000 Da, preferably 750 to 2500 Da, more preferably from 850 to 2000 Da and in particular from 1000 to 1600 Da.
  • oligopeptides which do not consist solely of the three glutamic acids but have further amino acids bound to this sequence.
  • These other amino acids are preferably selected from certain amino acids, while certain other representatives are less preferred.
  • oligopeptides used in the hair treatment agents contain tyrosine.
  • oligopeptides used in the hair treatment compositions contain leucine.
  • the oligopeptides used in the hair treatment compositions contain isoleucine. It is further preferred if the oligopeptides used in the hair treatment agents contain arginine.
  • oligopeptides used in the hair treatment compositions contain valine.
  • oligopeptides or amino acid sequences contained in the preferred oligopeptides are described below:
  • a particularly preferred oligopeptide additionally contains tyrosine, which is preferably linked via its acid function to the Glu-Glu-Glu sequence.
  • Preferred hair treatment compositions are therefore characterized in that the oligopeptide contained in them has at least one amino acid sequence Tyr-Glu-Glu-Glu, wherein the amino group is free or protonated and the carboxy groups may be free or deprotonated.
  • Another particularly preferred oligopeptide additionally contains isoleucine, which is preferably linked to the Glu-Glu-Glu sequence via its amino function.
  • Preferred hair treatment compositions are therefore characterized in that the oligopeptide contained in them has at least one amino acid sequence Glu-Glu-Glu-Ile, wherein the amino group is free or protonated and the carboxy groups may be free or deprotonated.
  • Oligopeptides having both of the aforementioned amino acids are preferred.
  • oligopeptides additionally contain arginine, which is preferably bound to isoleucine.
  • hair treatment agents are further preferred in which the oligopeptide contained has at least one amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg, where the amino groups are free or protonated and the carboxy groups may be free or deprotonated.
  • Still further preferred oligopeptides additionally contain valine, which is preferably bound to the arginine.
  • Further preferred hair treatment compositions are therefore characterized in that the oligopeptide contained in them at least one amino acid sequence Tyr-Glu-Glu-Glu-Ile- Arg-Val, wherein the amino groups are free or protonated and the carboxy groups may be present freely or deprotonated.
  • Still further preferred oligopeptides additionally contain leucine, which is preferably bound to the valine.
  • Further preferred hair treatment compositions are characterized in that the oligopeptide contained in them has at least one amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu, wherein the amino groups are free or protonated and the carboxy groups are free or deprotonated can.
  • Particularly preferred oligopeptides additionally contain leucine, which is preferably bound to the tyrosine.
  • Further preferred hair treatment compositions are characterized in that the oligopeptide contained in them has at least one amino acid sequence Leu-Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu, wherein the amino groups are free or protonated and the carboxy groups free or may be present deprotonated.
  • the agents contain at least two oligopeptides that meet the criteria mentioned above, but differ from each other.
  • hair treatment agents containing at least two mutually different oligopeptides A and B, both containing the amino acid sequence Glu-Glu-Glu are preferred.
  • Such mutually different oligopeptides A and B correspond to each other in that they carry three consecutive Glu amino acids in their amino acid sequence, but have differences in the upstream or downstream amino acids. Preference is given to mutually different peptides with partial agreement, which may well be greater than in the above-mentioned three amino acids.
  • compositions are characterized in that they contain at least two mutually different oligopeptides A and B, both of which contain the amino acid sequence Glu-Glu-Glu-Ile.
  • hair treatment agents containing at least two mutually different oligopeptides A and B, both containing the amino acid sequence Tyr-Glu-Glu-Glu.
  • hair treatment agents contain at least two mutually different oligopeptides A and B, both containing the amino acid sequence Tyr-Glu-Glu-Glu-Ile.
  • Very particularly preferred hair treatment compositions are characterized in that they contain at least two mutually different oligopeptides A and B, both of which contain the amino acid sequence Glu-Glu-Glu-Ile-Arg.
  • very particularly preferred hair treatment agents contain at least two mutually different oligopeptides A and B, both of which contain the amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg.
  • hair treatment agents containing at least two mutually different oligopeptides A and B, both of which contain the amino acid sequence Glu-Glu-Glu-Ile-Arg-Val, are further preferred embodiments of the present invention.
  • hair treatment compositions containing at least two mutually different oligopeptides A and B, both of which contain the amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val.
  • Still further preferred hair treatment agents contain at least two mutually different oligopeptides A and B, both containing the amino acid sequence Glu-Glu-Glu-Ile-Arg-Val-Leu.
  • Even more preferred hair treatment agents contain at least two mutually different oligopeptides A and B, both containing the amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu.
  • Particularly preferred hair treatment agents are characterized in that they contain at least two mutually different oligopeptides A and B, wherein the oligopeptide A has the amino acid sequence Leu-Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu, wherein the amino groups are free or protonated and the carboxy groups may be free or deprotonated and the oligopeptide B has the amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu, wherein the amino groups are free or protonated and the carboxy groups are free or may be present deprotonated.
  • Very particularly preferred agents of this last-mentioned embodiment contain, based on the weight of the composition, 0.00001 to 1% by weight of oligopeptide A and 0.00001 to 1% by weight of oligopeptide B.
  • Further preferred means of this latter embodiment contain - by weight of the agent -0.00005 to 0.1% by weight of oligopeptide A and 0.00005 to 0.1% by weight of oligopeptide B.
  • Still further preferred agents of this latter embodiment contain, based on the weight of the agent, from 0.0001 to 0.01% by weight of oligopeptide A and from 0.0001 to 0.001% by weight of oligopeptide B.
  • oligopeptides used in the context of the present invention which satisfy the abovementioned conditions, can advantageously be obtained from keratinic materials.
  • the hair treatment agents contain the oligopeptide having at least one amino acid sequence Glu-Glu-Glu, preferably in an amount of 0.01 to 10.0 wt%, and more preferably 0.05 to 5.0 wt%, respectively based on the weight of the ready-to-use hair treatment agent.
  • the hair treatment agents contain as the second essential ingredient - based on their weight - 0.0001 to 30 wt .-% methionylmethionine.
  • Methionylmethionine is the dipeptide of methionine and has the following structure:
  • the dipeptide methionylmethionine From the dipeptide methionylmethionine exist the four different stereoisomers DD, LL, DL and LD. Of the four stereoisomers, only the L-methionyl-L-methionine is natural, the three other dipeptides L-methionyl-D-methionine, D-methionyl-L-methionine and D-methionyl-D-methionine are all not natural. The described positive effects can be achieved with all four stereoisomeric dipeptides.
  • the Methionylmethionin can be used as DD / LL / LD / DL mixture, as DL / LD mixture or DD / LL mixture.
  • stereoisomeric dipeptide alone or in combination with one or two further stereoisomers is conceivable. If only one stereoisomeric dipeptide is used, preference is given to choosing L-methionyl-L-methionine or D-methionyl-D-methionine. both pairs DD / LL-methionylmethionine and DL / LD-methionylmethionine are diastereomeric to each other and have different physical data.
  • the diastereomeric pair DD / LL at room temperature has a solubility of 21.0 g / l in water, whereas the solubility of the diastereomeric pair DL / LD is 0.4 g / l.
  • These mixtures can be easily incorporated / dissolved in an aqueous phase or an aqueous-surfactant phase of a hair treatment agent.
  • the hair treatment compositions contain the methionyl methionine preferably in an amount of 0.01 to 5.0 wt .-% and particularly preferably from 0.1 to 1, 0 wt .-%, each based on the weight of the ready hair treatment agent.
  • the hair treatment agents give the hair treated with them more resilience, which is reflected in higher tensile strengths of the keratin fibers and in a reduction of the elasticity decrease, for example, when damaged by atmospheric agents.
  • the moisture balance of the keratinic fibers is stabilized, so that the combability improves and the aging process is delayed.
  • the hair treatment agents may contain other active ingredients and adjuvants. These are described below.
  • the hair treatment compositions additionally comprise at least one surfactant, surface-active substances being referred to as surfactants or as emulsifiers, depending on the field of application, and being selected from anionic, cationic, amphoteric / zwitterionic and nonionic surfactants and emulsifiers.
  • surfactants surface-active substances
  • emulsifiers depending on the field of application, and being selected from anionic, cationic, amphoteric / zwitterionic and nonionic surfactants and emulsifiers.
  • Preferred hair treatment agents are characterized in that they contain, based on their weight, 0.5 to 70% by weight, preferably 1 to 60% by weight and in particular 5 to 25% by weight of anionic (s) and / or nonionic ( s) and / or cationic (s) and / or amphoteric / zwitterionic surfactant (s).
  • Suitable anionic surfactants for the hair treatment agents are all anionic surfactants suitable for use on the human body. These are characterized by a water-solubilizing, anionic group such as a carboxylate, sulfate, Sulfonate or phosphate group and a lipophilic alkyl group having about 8 to 30 carbon atoms.
  • anionic group such as a carboxylate, sulfate, Sulfonate or phosphate group
  • a lipophilic alkyl group having about 8 to 30 carbon atoms.
  • glycol or polyglycol ether groups, ester, ether and amide groups and hydroxyl groups may be present in the molecule.
  • Amphoteric / zwitterionic surfactants are surface-active compounds which contain at least one quaternary ammonium group and at least one -COOH or -SO 3 (" 'group in the molecule ## STR16 ## Particularly suitable zwitterionic surfactants and emulsifiers are the so-called betaines such as the N-alkyl group.
  • N, N-dimethylammonium glycinates for example cocoalkyldimethylammonium glycinate
  • N-acylaminopropyl N, N-dimethylammonium glycinates for example cocoacylaminopropyldimethylammonium glycinate
  • 2-alkyl-3-carboxymethyl-3-hydroxyethylimidazolines having in each case 8 to 18 C atoms in the alkyl
  • a preferred zwitterionic surfactant is the fatty acid amide derivative known by the INCI name Cocamidopropyl Betaine.
  • Amphoteric / zwitterionic surfactants are also understood to mean those surface-active compounds which, apart from a Ce - C24-alkyl or -acyl group, contain at least one free amino group and at least one -COOH or -SOsH group and are capable of forming internal salts.
  • suitable amphoteric / zwitterionic surfactants are N-alkylglycines, N-alkylaminopropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids,
  • N-hydroxyethyl-N-alkylamidopropylglycines N-alkyltaurines, N-alkylsarcosines, 2-
  • Alkylaminopropion Acid and Alkylaminoessigkladren each having about 8 to 24 carbon atoms in the alkyl group.
  • Particularly preferred amphoteric / zwitterionic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C 12 -C 18 -acylsarcosine.
  • Nonionic surfactants and emulsifiers contain as hydrophilic group, for example, a polyol group, a polyalkylene glycol ether group or a combination of polyol and polyglycol ether group.
  • agents which in addition fatty alcohol (s) and / or fatty alcohol alkoxylate (s), preferably Ci2-22 fatty alcohol (s) and / or Ci2-22 fatty alcohol ethoxylate (s) having 10 to 30 EO units, particularly preferred Ci6-he-fatty alcohol (s) and / or Ci6-i 8-fatty alcohol ethoxylate (s) having 12 to 20 EO units, preferably in amounts of 5 to 20 wt .-%, preferably from 7.5 to 17.5 wt .-% and in particular from 10 to 15 wt .-%, each based on the weight of the hair treatment agent.
  • hair treatment compositions which, by weight, contain from 0.1 to 20% by weight, preferably from 0.25 to 17.5% by weight and in particular from 5 to 15% by weight of anionic surfactant (s ), particularly preferred fatty alcohol ether sulfates of the formula
  • n represents values of from 5 to 21, preferably from 7 to 19, particularly preferably from 9 to 17 and in particular from 1 to 13 and k for values of 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10, preferably 1, 2 or 3 and especially 2
  • M is a cation from the group Na + , K + NH4 + , Vz Mg 2+ , 2Zn 2+ , preferably Na + , stand.
  • the hair treatment agents may contain 0.01 to 10% by weight of at least one polymer from the group of cationic and / or amphoteric polymers.
  • Cationic or amphoteric polymers are to be understood as meaning polymers which have a group in the main and / or side chain which may be “temporary” or “permanent” cationic.
  • Periodently cationic refers to those polymers which have a cationic group regardless of the pH of the agent. These are usually polymers containing a quaternary nitrogen atom, for example in the form of an ammonium group. Preferred cationic groups are quaternary ammonium groups.
  • those polymers in which the quaternary ammonium group is bonded via a C1-C4 hydrocarbon group to a polymer main chain constructed from acrylic acid, methacrylic acid or derivatives thereof have proven to be particularly suitable.
  • hair treatment agents may also contain amphoteric polymers. These have in addition to the cationically charged group (s) at least one negatively charged group in the molecule and are also referred to as zwitterionic polymers.
  • the polymer or polymers are used within narrower ranges.
  • agents are preferred which - based on their weight - 0.05 to 7.5 wt .-%, preferably 0.1 to 5 wt .-%, particularly preferably 0.2 to 3.5 wt .-% and in particular From 0.25 to 2.5% by weight of amphoteric polymer (s).
  • amphoteric polymers are or are not included in the compositions
  • further preferred agents are characterized in that they contain, based on their weight, from 0.05 to 7.5% by weight, preferably from 0.1 to 5% by weight. %, more preferably from 0.2 to 3.5% by weight and in particular from 0.25 to 2.5% by weight of cationic polymer (s).
  • Preferred cationic polymers are selected from:
  • Poly (methacryloyloxyethyltrimethylammonium chloride) (INCI: Polyquaternium-37) and / or; quaternized cellulose derivatives (INCI: Polyquaternium 10) and / or
  • Hair treatment compositions contain the silicone (s) preferably in amounts of from 0.1 to 10% by weight, preferably from 0.25 to 7% by weight and in particular from 0, 5 to 5 wt .-%, each based on the total agent.
  • suitable ingredients include nonionic polymers, fatty substances, waxes, protein hydrolysates, amino acids, vitamins, provitamins, vitamin precursors, betaines, biochinones, purines (derivatives), taurine (derivatives), L-carnitine (salts), panthenol, panthothenic acid, 2-furanones, 2 furanone derivatives, ectoine, allantoin, plant extracts, ester oils, UV light stabilizers, structurants, thickeners, electrolytes, pH modifiers, swelling agents, dyes, anti-dandruff agents, chelants, opacifiers, pearlescers, pigments, stabilizers, propellants, antioxidants, perfume oils and / or preservative.
  • the hair treatment compositions have advantageous properties and also confer advantageous properties on the hair treated with them. Especially in the hair and Scalp treatment benefits were observed beyond the benefits of oligopeptides and methionylmethionine alone.
  • the hair treatment agents increase the elasticity of the hair treated with them and lead to an inner-structural strengthening of the hair fibers, which is reflected for example in higher melting temperatures in the differential thermal analysis.
  • there is a hydrophobization of the hair surface which manifests itself in an increase in the contact angle of water droplets on the hair surface.
  • wet and dry combabilities There is also an improvement in wet and dry combabilities.
  • a further subject of the present invention is accordingly the use of a combination of an oligopeptide which has at least one amino acid sequence Glu-Glu-Glu
  • amino group may be free or protonated and the carboxy groups may be free or deprotonated, and methionylmethionine, preferably in a hair treatment agent, for improving at least one of the properties
  • Yet another object of the present invention is a method for improving at least one of the properties Tensile strength of keratinic fibers, especially human hair; Stabilizing the moisture balance of keratinic fibers, in particular human hair;
  • Fibers in particular human hair
  • a hair treatment composition containing - in each case based on its weight - a) 0.00001 to 20 wt .-% of at least one oligopeptide having at least one amino acid sequence Glu-Glu-Glu, wherein the amino group is free or protonated and the carboxy Groups may be free or deprotonated,
  • * contains oligopeptide with the amino acid sequence Glu-Glu-Glu

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

The invention relates to hair treatment products which contain, in relation to their respective weight, 0.0001 to 20 wt.-% of at least one oligopeptide which has at least one amino acid sequence Glu-Glu-Glu (I), the amino group being free or protonated and the carboxyl groups being free or deprotonated, and 0.0001 to 30 wt.-% of a methionyl methionine. The hair treatment products containing methionyl methionine and certain oligopeptides have an improved positive effect on hair and the hair follicle.

Description

HAARBEHANDLUNGSMITTEL MIT METHIONYLMETHIONIN UND EINEM OLIGOPEPTID MIT EINER GLU-GLU-GLU SEQUENZ  HAIR TREATMENT AGENT WITH METHIONYLMETHIONINE AND AN OLIGOPEPTIDE WITH A GLU-GLU-GLU SEQUENCE
Die Erfindung betrifft Haarbehandlungsmittel, insbesondere Shampoos und sogenannte Konditionierer, mit einer Wirkstoffkombination zur schonenden und effektiven Pflege der Haare. The invention relates to hair treatment compositions, in particular shampoos and so-called conditioners, with a combination of active ingredients for gentle and effective care of the hair.
Nicht zuletzt durch starke Beanspruchung der Haare, beispielsweise durch Färben oder Dauerwellen als auch durch Reinigung der Haare mit Shampoos und durch Umweltbelastungen, nimmt die Bedeutung von Pflegeprodukten mit möglichst langanhaltender Wirkung zu. Derartige Pflegemittel beeinflussen die natürliche Struktur und die Eigenschaften der Haare. So können anschließend an solche Pflegebehandlungen beispielsweise die Nass- und Trockenkämmbarkeit des Haares, der Halt und die Fülle des Haares optimiert sein oder die Haare vor erhöhtem Spliss geschützt sein. Last but not least, by heavy use of the hair, for example by dyeing or perming as well as by cleaning the hair with shampoos and environmental pollution, the importance of care products with the longest possible effect increases. Such care products affect the natural structure and properties of the hair. Thus, for example, the wet and dry combability of the hair, the hold and the fullness of the hair can be optimized or the hair can be protected from increased split ends following such care treatments.
Es ist daher seit langem üblich, Haare einer speziellen Nachbehandlung zu unterziehen. Dabei werden, üblicherweise in Form einer Spülung, die Haare mit speziellen Wirkstoffen, beispielsweise quaternären Ammoniumsalzen oder speziellen Polymeren, behandelt. Durch diese Behandlung werden je nach Formulierung die Kämmbarkeit, der Halt und die Fülle der Haare verbessert und die Splissrate verringert. It has therefore long been customary to subject hair to a special after-treatment. In this case, the hair is treated with special active ingredients, for example quaternary ammonium salts or special polymers, usually in the form of a rinse. Depending on the formulation, this treatment improves the combability, the hold and the fullness of the hair and reduces the split rate.
Ebenso sind im Stand der Technik multifunktionale kosmetische Produkte bekannt. Insbesondere zählen hierzu die so genannten„2 in 1 " Shampoos, welche nicht nur das Haar reinigen, sondern es auch konditionieren. Derartige Produkte werden vom Verbraucher sehr geschätzt, weil sie durch ihre Produktleistung mindestens einen Verfahrensschritt, beispielsweise das Konditionieren mit einer klassischen Haarspülung, erübrigen. Likewise, multifunctional cosmetic products are known in the prior art. In particular, these include the so-called "2 in 1" shampoos, which not only cleanse the hair, but also condition it.These products are highly appreciated by the consumer because of their product performance, at least one process step, for example, conditioning with a classical hair conditioner; unnecessary.
Der Einsatz spezieller Oligopeptide zur Pflege von keratinischen Fasern ist beispielsweise aus der WO 2010/026010 A1 bekannt. Dort werden insbesondere Oligopeptide mit der Sequenz Tyr-Glu-Glu-Glu- Ile-Arg-Val-Leu als besonders geeignet für die Haarpflege offenbart. The use of special oligopeptides for the care of keratinic fibers is known, for example, from WO 2010/026010 A1. In particular, oligopeptides with the sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu are disclosed as being particularly suitable for hair care.
Es besteht nach wie vor das Bedürfnis, Wirkstoffe oder Wirkstoffkombinationen für kosmetische Mittel mit guten pflegenden Eigenschaften bereitzustellen und kosmetische Mittel diesbezüglich weiterzuentwickeln. There is still the need to provide active ingredients or combinations of active ingredients for cosmetic products with good care properties and to develop cosmetic products in this regard.
Es wurde nun gefunden, dass eine Kombination von bestimmten Oligopeptiden mit Methionylmethionin eine besonders positive Wirkung auf damit behandeltem Haar und den Haarfollikel besitzt. Ein erster Gegenstand der vorliegenden Erfindung sind Haarbehandlungsmittel, enthaltend - jeweils bezogen auf ihr Gewicht - a) 0,00001 bis 20 Gew.-% mindestens eines Oligopeptids, das mindestens eine Aminosäuresequenz Glu-Glu-Glu It has now been found that a combination of certain oligopeptides with methionylmethionine has a particularly positive effect on hair and hair follicles treated therewith. A first object of the present invention are hair treatment compositions containing - each based on their weight - a) 0.00001 to 20 wt .-% of at least one oligopeptide, the at least one amino acid sequence Glu-Glu-Glu
aufweist, wobei die Amino-Gruppe frei oder protoniert und die Carboxy-Gruppen frei oder deprotoniert vorliegen können, und  wherein the amino group may be free or protonated and the carboxy groups may be free or deprotonated, and
0,0001 bis 30 Gew.-% Methionylmethionin.  0.0001 to 30% by weight of methionylmethionine.
In dieser wie in allen nachstehenden Formeln bedeutet das eingeklammerte Wasserstoffatom der Aminogruppe ebenso wie die eingeklammerte Hydroxygruppe der Säurefunktion, dass die betreffenden Gruppen als solche vorhanden sein können (dann handelt es sich um ein Oligopeptid mit der betreffenden Anzahl an Aminosäuren wie dargestellt - in der vorstehenden Formel sind es drei Aminosäuren) oder aber, dass die Aminosäuresequenz in einem Oligopeptid vorliegt, das noch weitere Aminosäuren umfasst - je nachdem, wo die weitere(n) Aminosäure(n) gebunden ist/sind, sind die eingeklammerten Bestandteile der oben genannten Formel durch den/die weiteren Aminosäurerest(e) ersetzt. In this formula as well as in the formulas below, the parenthetized hydrogen atom of the amino group, as well as the parenthetical group of the acid function, means that the groups concerned may be present as such (then an oligopeptide having the relevant number of amino acids as shown) Formula are three amino acids) or that the amino acid sequence is present in an oligopeptide, which still contains other amino acids - depending on where the other amino acid (s) is / are bound, the parent compound of the above formula by replaced the other amino acid residue (s).
Haarbehandlungsmittel im Sinne der vorliegenden Erfindung sind beispielsweise Haarshampoos, Haarkonditionierer, konditionierende Shampoos, Haarsprays, Haarspülungen, Haarkuren, Haarpackungen, Haar-Tonics, Dauerwell-Fixierlösungen, Haarfärbeshampoos, Haarfärbemittel, Haarfestiger, Haarlegemittel, Haarstyling-Zubereitungen, Fönwell-Lotionen, Schaumfestiger, Haargele, Haarwachse oder deren Kombinationen. Im Hinblick auf die Tatsache, dass insbesondere Männer oft die Anwendung mehrerer unterschiedlicher Mittel und/oder mehrere Anwendungsschritte scheuen, sind solche Mittel bevorzugt, die der Mann ohnehin anwendet. Bevorzugte Mittel sind daher Shampoos, Konditioniermittel oder Haar-Tonics. Hair treatment compositions for the purposes of the present invention are, for example, hair shampoos, hair conditioners, conditioning shampoos, hairsprays, hair conditioners, hair conditioners, hair wraps, hair tonics, perming solutions, hair dye shampoos, hair dyes, hair fixatives, hair dressings, hairstyling preparations, hair lotions, mousses, hair gels , Hair waxes or their combinations. In view of the fact that, in particular, men often shy away from the use of several different means and / or several application steps, preference is given to means which the man uses anyway. Preferred agents are therefore shampoos, conditioners or hair tonics.
Die Haarbehandlungsmittel enthalten - bezogen auf ihr Gewicht - 0,00001 bis 20 Gew.-% mindestens eines Oligopeptids, das mindestens eine Aminosäuresequenz Glu-Glu-Glu, das heißt mindestens drei aufeinander folgende Glutaminsäuren aufweist. The hair treatment compositions contain - based on their weight - 0.00001 to 20 wt .-% at least an oligopeptide having at least one amino acid sequence Glu-Glu-Glu, that is at least three consecutive glutamic acids.
Oligopeptide im Sinne der vorliegenden Anmeldung sind durch Peptid-Bindungen Säureamid-artig verknüpfte Kondensationsprodukte von Aminosäuren, die mindestens 3 und maximal 25 Aminosäuren umfassen. Oligopeptides in the sense of the present application are acid amide-like linked by peptide bonds condensation products of amino acids comprising at least 3 and a maximum of 25 amino acids.
In bevorzugten Haarbehandlungsmitteln umfasst das Oligopeptid 5 bis 15 Aminosäuren, vorzugsweise 6 bis 13 Aminosäuren, besonders bevorzugt 7 bis 12 Aminosäuren und insbesondere 8, 9 oder 10 Aminosäuren. In preferred hair treatment compositions, the oligopeptide comprises 5 to 15 amino acids, preferably 6 to 13 amino acids, more preferably 7 to 12 amino acids and especially 8, 9 or 10 amino acids.
Je nachdem, ob weitere Aminosäuren an die Sequenz Glu-Glu-Glu gebunden sind und je nach Art dieser Aminosäuren kann die Molmasse des in den Haarbehandlungsmitteln enthaltenen Oligopeptids variieren. Bevorzugte Haarbehandlungsmittel sind dadurch gekennzeichnet, dass das Oligopeptid eine Molmasse von 650 bis 3000 Da, vorzugsweise von 750 bis 2500 Da, besonders bevorzugt von 850 bis 2000 Da und insbesondere von 1000 bis 1600 Da aufweist. Depending on whether further amino acids are bound to the sequence Glu-Glu-Glu and depending on the nature of these amino acids, the molecular weight of the oligopeptide contained in the hair treatment agents may vary. Preferred hair treatment compositions are characterized in that the oligopeptide has a molecular weight of from 650 to 3000 Da, preferably from 750 to 2500 Da, particularly preferably from 850 to 2000 Da and in particular from 1000 to 1600 Da.
Zusammenfassend sind bevorzugte Haarbehandlungsmittel dadurch gekennzeichnet, dass das eingesetzte Oligopeptid 5 bis 15 Aminosäuren, vorzugsweise 6 bis 13 Aminosäuren, besonders bevorzugt 7 bis 12 Aminosäuren und insbesondere 8, 9 oder 10 Aminosäuren umfasst und eine Molmasse von 650 bis 3000 Da, vorzugsweise von 750 bis 2500 Da, besonders bevorzugt von 850 bis 2000 Da und insbesondere von 1000 bis 1600 Da aufweist. In summary, preferred hair treatment compositions are characterized in that the oligopeptide used comprises 5 to 15 amino acids, preferably 6 to 13 amino acids, more preferably 7 to 12 amino acids and especially 8, 9 or 10 amino acids and a molecular weight of 650 to 3000 Da, preferably 750 to 2500 Da, more preferably from 850 to 2000 Da and in particular from 1000 to 1600 Da.
Wie aus der bevorzugten Anzahl von Aminosäuren in den Oligopeptiden und dem bevorzugten Molmassenbereich zu ersehen ist, werden vorzugsweise Oligopeptide eingesetzt, die nicht allein aus den drei Glutaminsäuren bestehen, sondern weitere, an diese Sequenz gebundene Aminosäuren aufweisen. Diese weiteren Aminosäuren sind vorzugsweise aus bestimmten Aminosäuren ausgewählt, während bestimmte andere Vertreter weniger bevorzugt sind. As can be seen from the preferred number of amino acids in the oligopeptides and the preferred molecular weight range, it is preferred to use oligopeptides which do not consist solely of the three glutamic acids but have further amino acids bound to this sequence. These other amino acids are preferably selected from certain amino acids, while certain other representatives are less preferred.
Demgegenüber ist es bevorzugt, wenn die in den Haarbehandlungsmitteln eingesetzten Oligopeptide Tyrosin enthalten.  In contrast, it is preferred if the oligopeptides used in the hair treatment agents contain tyrosine.
Es ist bevorzugt, wenn die in den Haarbehandlungsmitteln eingesetzten Oligopeptide Leucin enthalten. It is preferred if the oligopeptides used in the hair treatment compositions contain leucine.
Weiter bevorzugt ist es, wenn die in den Haarbehandlungsmitteln eingesetzten Oligopeptide Isoleucin enthalten. Weiter bevorzugt ist es, wenn die in den Haarbehandlungsmitteln eingesetzten Oligopeptide Arginin enthalten. It is further preferred if the oligopeptides used in the hair treatment compositions contain isoleucine. It is further preferred if the oligopeptides used in the hair treatment agents contain arginine.
Weiter bevorzugt ist es, wenn die in den Haarbehandlungsmitteln eingesetzten Oligopeptide Valin enthalten. It is further preferred if the oligopeptides used in the hair treatment compositions contain valine.
Besonders bevorzugte Oligopeptide oder in den bevorzugten Oligopeptiden enthaltene Aminosäuresequenzen werden nachstehend beschrieben: Particularly preferred oligopeptides or amino acid sequences contained in the preferred oligopeptides are described below:
Ein besonders bevorzugtes Oligopeptid enthält zusätzlich Tyrosin, das vorzugsweise über seine Säurefunktion an die Glu-Glu-Glu-Sequenz gebunden ist. Bevorzugte Haarbehandlungsmittel sind daher dadurch gekennzeichnet, dass das in ihnen enthaltene Oligopeptid mindestens eine Aminosäuresequenz Tyr-Glu-Glu-Glu aufweist, wobei die Amino-Gruppe frei oder protoniert und die Carboxy-Gruppen frei oder deprotoniert vorliegen können. A particularly preferred oligopeptide additionally contains tyrosine, which is preferably linked via its acid function to the Glu-Glu-Glu sequence. Preferred hair treatment compositions are therefore characterized in that the oligopeptide contained in them has at least one amino acid sequence Tyr-Glu-Glu-Glu, wherein the amino group is free or protonated and the carboxy groups may be free or deprotonated.
Ein weiteres besonders bevorzugtes Oligopeptid enthält zusätzlich Isoleucin, das vorzugsweise über seine Aminofunktion an die Glu-Glu-Glu-Sequenz gebunden ist. Bevorzugte Haarbehandlungsmittel sind daher dadurch gekennzeichnet, dass das in ihnen enthaltene das Oligopeptid mindestens eine Aminosäuresequenz Glu-Glu-Glu-Ile aufweist, wobei die Amino-Gruppe frei oder protoniert und die Carboxy-Gruppen frei oder deprotoniert vorliegen können. Another particularly preferred oligopeptide additionally contains isoleucine, which is preferably linked to the Glu-Glu-Glu sequence via its amino function. Preferred hair treatment compositions are therefore characterized in that the oligopeptide contained in them has at least one amino acid sequence Glu-Glu-Glu-Ile, wherein the amino group is free or protonated and the carboxy groups may be free or deprotonated.
Oligopeptide, die beide vorgenannten Aminosäuren (Tyrosin und Isoleucin) aufweisen, sind bevorzugt. Besonders bevorzugt sind dabei Haarbehandlungsmittel, bei denen das in ihnen enthaltene Oligopeptid mindestens eine Aminosäuresequenz Tyr-Glu-Glu-Glu-Ile aufweist, wobei die Amino-Gruppe frei oder protoniert und die Carboxy-Gruppen frei oder deprotoniert vorliegen können. Oligopeptides having both of the aforementioned amino acids (tyrosine and isoleucine) are preferred. Hair treatment agents in which the oligopeptide contained in them has at least one amino acid sequence Tyr-Glu-Glu-Glu-Ile, the amino group being free or protonated and the carboxy groups being free or deprotonated, are particularly preferred.
Weiter bevorzugte Oligopeptide enthalten zusätzlich Arginin, das vorzugsweise an Isoleucin gebunden vorliegt. Further preferred oligopeptides additionally contain arginine, which is preferably bound to isoleucine.
Entsprechend sind Haarbehandlungsmittel weiter bevorzugt, in denen das enthaltene Oligopeptid mindestens eine Aminosäuresequenz Tyr-Glu-Glu-Glu-Ile-Arg aufweist, wobei die Amino-Gruppen frei oder protoniert und die Carboxy-Gruppen frei oder deprotoniert vorliegen können. Accordingly, hair treatment agents are further preferred in which the oligopeptide contained has at least one amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg, where the amino groups are free or protonated and the carboxy groups may be free or deprotonated.
Noch weiter bevorzugte Oligopeptide enthalten zusätzlich Valin, das vorzugsweise an das Arginin gebunden vorliegt. Weiter bevorzugte Haarbehandlungsmittel sind daher dadurch gekennzeichnet, dass das in ihnen enthaltene Oligopeptid mindestens eine Aminosäuresequenz Tyr-Glu-Glu-Glu-Ile- Arg-Val aufweist, wobei die Amino-Gruppen frei oder protoniert und die Carboxy-Gruppen frei oder deprotoniert vorliegen können. Still further preferred oligopeptides additionally contain valine, which is preferably bound to the arginine. Further preferred hair treatment compositions are therefore characterized in that the oligopeptide contained in them at least one amino acid sequence Tyr-Glu-Glu-Glu-Ile- Arg-Val, wherein the amino groups are free or protonated and the carboxy groups may be present freely or deprotonated.
Noch weiter bevorzugte Oligopeptide enthalten zusätzlich Leucin, das vorzugsweise an das Valin gebunden vorliegt. Weiter bevorzugte Haarbehandlungsmittel sind dadurch gekennzeichnet, dass das in ihnen enthaltene Oligopeptid mindestens eine Aminosäuresequenz Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu aufweist, wobei die Amino-Gruppen frei oder protoniert und die Carboxy-Gruppen frei oder deprotoniert vorliegen können. Still further preferred oligopeptides additionally contain leucine, which is preferably bound to the valine. Further preferred hair treatment compositions are characterized in that the oligopeptide contained in them has at least one amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu, wherein the amino groups are free or protonated and the carboxy groups are free or deprotonated can.
Insbesondere bevorzugte Oligopeptide enthalten zusätzlich Leucin, das vorzugsweise an das Tyrosin gebunden vorliegt. Weiter bevorzugte Haarbehandlungsmittel sind dadurch gekennzeichnet, dass das in ihnen enthaltene Oligopeptid mindestens eine Aminosäuresequenz Leu-Tyr-Glu-Glu-Glu-Ile-Arg-Val- Leu aufweist, wobei die Amino-Gruppen frei oder protoniert und die Carboxy-Gruppen frei oder deprotoniert vorliegen können. Particularly preferred oligopeptides additionally contain leucine, which is preferably bound to the tyrosine. Further preferred hair treatment compositions are characterized in that the oligopeptide contained in them has at least one amino acid sequence Leu-Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu, wherein the amino groups are free or protonated and the carboxy groups free or may be present deprotonated.
Ganz besonders bevorzugt enthalten die Mittel mindestens zwei Oligopeptide, die den vorstehend genannten Kriterien genügen, sich aber voneinander unterscheiden. So sind beispielsweise Haarbehandlungsmittel bevorzugt, die mindestens zwei voneinander verschiedene Oligopeptide A und B enthalten, die beide die Aminosäuresequenz Glu-Glu-Glu enthalten. Most preferably, the agents contain at least two oligopeptides that meet the criteria mentioned above, but differ from each other. For example, hair treatment agents containing at least two mutually different oligopeptides A and B, both containing the amino acid sequence Glu-Glu-Glu, are preferred.
Solche voneinander unterschiedlichen Oligopeptide A und B entsprechen einander darin, dass sie drei aufeinander folgende Glu-Aminosäuren in ihrer Aminosäuresequenz tragen, besitzen aber in den davor oder dahinter gebundenen Aminosäuren Unterschiede. Bevorzugt sind voneinander verschiedene Peptide mit partieller Übereinstimmung, die durchaus größer sein kann als in den vorstehend genannten drei Aminosäuren. Such mutually different oligopeptides A and B correspond to each other in that they carry three consecutive Glu amino acids in their amino acid sequence, but have differences in the upstream or downstream amino acids. Preference is given to mutually different peptides with partial agreement, which may well be greater than in the above-mentioned three amino acids.
So sind weiter bevorzugte Haarbehandlungsmittel dadurch gekennzeichnet, dass sie mindestens zwei voneinander verschiedene Oligopeptide A und B enthalten, die beide die Aminosäuresequenz Glu-Glu- Glu-Ile enthalten. Thus, further preferred hair treatment compositions are characterized in that they contain at least two mutually different oligopeptides A and B, both of which contain the amino acid sequence Glu-Glu-Glu-Ile.
Ebenfalls bevorzugt sind Haarbehandlungsmittel, die mindestens zwei voneinander verschiedene Oligopeptide A und B enthalten, die beide die Aminosäuresequenz Tyr-Glu-Glu-Glu enthalten. Also preferred are hair treatment agents containing at least two mutually different oligopeptides A and B, both containing the amino acid sequence Tyr-Glu-Glu-Glu.
Ebenfalls noch weiter bevorzugte Haarbehandlungsmittel enthalten mindestens zwei voneinander verschiedene Oligopeptide A und B, die beide die Aminosäuresequenz Tyr-Glu-Glu-Glu-Ile enthalten. Ganz besonders bevorzugte Haarbehandlungsmittel sind dadurch gekennzeichnet, dass sie mindestens zwei voneinander verschiedene Oligopeptide A und B enthalten, die beide die Aminosäuresequenz Glu-Glu-Glu-Ile-Arg enthalten. Also, even more preferred hair treatment agents contain at least two mutually different oligopeptides A and B, both containing the amino acid sequence Tyr-Glu-Glu-Glu-Ile. Very particularly preferred hair treatment compositions are characterized in that they contain at least two mutually different oligopeptides A and B, both of which contain the amino acid sequence Glu-Glu-Glu-Ile-Arg.
Ebenfalls ganz besonders bevorzugte Haarbehandlungsmittel enthalten mindestens zwei voneinander verschiedene Oligopeptide A und B, die beide die Aminosäuresequenz Tyr-Glu-Glu-Glu-Ile-Arg enthalten. Also very particularly preferred hair treatment agents contain at least two mutually different oligopeptides A and B, both of which contain the amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg.
Vorzugsweise besteht eine noch größere strukturelle Übereinstimmung in den Oligopeptiden. So sind Haarbehandlungsmittel, die mindestens zwei voneinander verschiedene Oligopeptide A und B enthalten, die beide die Aminosäuresequenz Glu-Glu-Glu-Ile-Arg-Val enthalten, weitere bevorzugte Ausführungsformen der vorliegenden Erfindung. Preferably, there is an even greater structural match in the oligopeptides. Thus, hair treatment agents containing at least two mutually different oligopeptides A and B, both of which contain the amino acid sequence Glu-Glu-Glu-Ile-Arg-Val, are further preferred embodiments of the present invention.
Ebenfalls bevorzugte Ausführungsformen sind Haarbehandlungsmittel, die mindestens zwei voneinander verschiedene Oligopeptide A und B enthalten, die beide die Aminosäuresequenz Tyr-Glu- Glu-Glu-Ile-Arg-Val enthalten. Also preferred embodiments are hair treatment compositions containing at least two mutually different oligopeptides A and B, both of which contain the amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val.
Noch weiter bevorzugte Haarbehandlungsmittel enthalten mindestens zwei voneinander verschiedene Oligopeptide A und B, die beide die Aminosäuresequenz Glu-Glu-Glu-Ile-Arg-Val-Leu enthalten. Still further preferred hair treatment agents contain at least two mutually different oligopeptides A and B, both containing the amino acid sequence Glu-Glu-Glu-Ile-Arg-Val-Leu.
Ebenfalls noch weiter bevorzugte Haarbehandlungsmittel enthalten mindestens zwei voneinander verschiedene Oligopeptide A und B, die beide die Aminosäuresequenz Tyr-Glu-Glu-Glu-Ile-Arg-Val- Leu enthalten. Even more preferred hair treatment agents contain at least two mutually different oligopeptides A and B, both containing the amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu.
Insbesondere bevorzugte Haarbehandlungsmittel sind dadurch gekennzeichnet, dass sie mindestens zwei voneinander verschiedene Oligopeptide A und B enthalten, wobei das Oligopeptid A die Aminosäuresequenz Leu-Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu aufweist, wobei die Amino-Gruppen frei oder protoniert und die Carboxy-Gruppen frei oder deprotoniert vorliegen können und das Oligopeptid B die Aminosäuresequenz Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu aufweist, wobei die Amino-Gruppen frei oder protoniert und die Carboxy-Gruppen frei oder deprotoniert vorliegen können. Particularly preferred hair treatment agents are characterized in that they contain at least two mutually different oligopeptides A and B, wherein the oligopeptide A has the amino acid sequence Leu-Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu, wherein the amino groups are free or protonated and the carboxy groups may be free or deprotonated and the oligopeptide B has the amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu, wherein the amino groups are free or protonated and the carboxy groups are free or may be present deprotonated.
Ganz besonders bevorzugte Mittel dieser letztgenannten Ausführungsform enthalten - bezogen auf das Gewicht des Mittels - 0,00001 bis 1 Gew.-% Oligopeptid A und 0,00001 bis 1 Gew.-% Oligopeptid B. Very particularly preferred agents of this last-mentioned embodiment contain, based on the weight of the composition, 0.00001 to 1% by weight of oligopeptide A and 0.00001 to 1% by weight of oligopeptide B.
Weiter bevorzugte Mittel dieser letztgenannten Ausführungsform enthalten - bezogen auf das Gewicht des Mittels -0,00005 bis 0,1 Gew.-% Oligopeptid A und 0,00005 bis 0,1 Gew.-% Oligopeptid B. Further preferred means of this latter embodiment contain - by weight of the agent -0.00005 to 0.1% by weight of oligopeptide A and 0.00005 to 0.1% by weight of oligopeptide B.
Noch weiter bevorzugte Mittel dieser letztgenannten Ausführungsform enthalten - bezogen auf das Gewicht des Mittels -0,0001 bis 0,01 Gew.-% Oligopeptid A und 0,0001 bis 0,001 Gew.-% Oligopeptid B. Still further preferred agents of this latter embodiment contain, based on the weight of the agent, from 0.0001 to 0.01% by weight of oligopeptide A and from 0.0001 to 0.001% by weight of oligopeptide B.
Die im Rahmen der vorliegenden Erfindung eingesetzten Oligopeptide, die den vorstehend genannten Bedingungen genügen, können vorteilhafterweise aus keratinischen Materialien gewonnen werden. The oligopeptides used in the context of the present invention, which satisfy the abovementioned conditions, can advantageously be obtained from keratinic materials.
Die Haarbehandlungsmittel enthalten das Oligopeptid, das mindestens eine Aminosäuresequenz Glu- Glu-Glu aufweist, bevorzugt in einer Menge von 0,01 bis 10,0 Gew.-% und besonders bevorzugt von 0,05 bis 5,0 Gew.-%, jeweils bezogen auf das Gewicht des anwendungsbereiten Haarbehandlungsmittels. The hair treatment agents contain the oligopeptide having at least one amino acid sequence Glu-Glu-Glu, preferably in an amount of 0.01 to 10.0 wt%, and more preferably 0.05 to 5.0 wt%, respectively based on the weight of the ready-to-use hair treatment agent.
Die Haarbehandlungsmittel enthalten als zweiten wesentlichen Inhaltstoff - bezogen auf ihr Gewicht - 0,0001 bis 30 Gew.-% Methionylmethionin. The hair treatment agents contain as the second essential ingredient - based on their weight - 0.0001 to 30 wt .-% methionylmethionine.
Methionylmethionin ist das Dipeptid von Methionin und weist folgende Struktur auf: Methionylmethionine is the dipeptide of methionine and has the following structure:
Vom Dipeptid Methionylmethionin existieren die vier verschiedenen Stereoisomere DD, LL, DL und LD. Von den vier Stereoisomeren ist nur das L-Methionyl-L-methionin natürlich, die drei anderen Dipeptide L-Methionyl-D-methionin, D-Methionyl-L-methionin und D-Methionyl-D-methionin sind alle nicht natürlich. Die beschriebenen positiven Wirkungen können mit allen vier stereoisomeren Dipeptiden erzielt werden. Das Methionylmethionin kann als DD/LL/LD/DL-Mischung, als DL/LD-Mischung oder DD/LL-Mischung eingesetzt werden. Prinzipiell ist auch der Einsatz eines stereoisomeren Dipeptids alleine oder in Kombination mit einem oder zwei weiteren Stereoisomeren denkbar. Wird nur ein stereoisomeres Dipeptid eingesetzt, werden vorzugsweise das L-Methionyl-L-methionin oder das D- Methionyl-D-methionin gewählt. beiden Paare DD/LL-Methionylmethionin und DL/LD-Methionylmethionin sind diastereomer zueinander und haben unterschiedliche physikalische Daten. So besitzt beispielsweise das Diastereomerenpaar DD/LL bei Raumtemperatur eine Löslichkeit von 21 ,0 g/l in Wasser, wohingegen die Löslichkeit vom Diastereomerenpaar DL/LD bei 0,4 g/l liegt. Entsprechend kann es bevorzugt sein, das Methionylmethionin als DD/LL-Mischung oder als DD/LL/LD/DL-Mischung mit einem hohen Anteil an dem DD/LL-Diastereomerenpaar einzusetzen. Diese Mischungen lassen sich einfach in einer wässrigen Phase oder einer wässrig-tensidischen Phase eines Haarbehandlungsmittels einarbeiten/lösen. From the dipeptide methionylmethionine exist the four different stereoisomers DD, LL, DL and LD. Of the four stereoisomers, only the L-methionyl-L-methionine is natural, the three other dipeptides L-methionyl-D-methionine, D-methionyl-L-methionine and D-methionyl-D-methionine are all not natural. The described positive effects can be achieved with all four stereoisomeric dipeptides. The Methionylmethionin can be used as DD / LL / LD / DL mixture, as DL / LD mixture or DD / LL mixture. In principle, the use of a stereoisomeric dipeptide alone or in combination with one or two further stereoisomers is conceivable. If only one stereoisomeric dipeptide is used, preference is given to choosing L-methionyl-L-methionine or D-methionyl-D-methionine. both pairs DD / LL-methionylmethionine and DL / LD-methionylmethionine are diastereomeric to each other and have different physical data. Thus, for example, the diastereomeric pair DD / LL at room temperature has a solubility of 21.0 g / l in water, whereas the solubility of the diastereomeric pair DL / LD is 0.4 g / l. Accordingly, it may be preferable to use the methionylmethionine as a DD / LL mixture or as a DD / LL / LD / DL mixture with a high proportion of the DD / LL diastereomeric pair. These mixtures can be easily incorporated / dissolved in an aqueous phase or an aqueous-surfactant phase of a hair treatment agent.
Die Haarbehandlungsmittel enthalten das Methionylmethionin bevorzugt in einer Menge von 0,01 bis 5,0 Gew.-% und besonders bevorzugt von 0,1 bis 1 ,0 Gew.-%, jeweils bezogen auf das Gewicht des anwendungsbereiten Haarbehandlungsmittels. The hair treatment compositions contain the methionyl methionine preferably in an amount of 0.01 to 5.0 wt .-% and particularly preferably from 0.1 to 1, 0 wt .-%, each based on the weight of the ready hair treatment agent.
Es hat sich gezeigt, dass der Einsatz der Kombination aus ausgewählten Oligopeptiden und Methionylmethionin den Haarbehandlungsmitteln herausragende Eigenschaften verleiht. Die Haarbehandlungsmittel verleihen den mit ihnen behandelten Haaren mehr Spannkraft, was sich in höheren Zugfestigkeiten der Keratinfasern und in einer Verringerung der Elastizitätsabnahme, zum Beispiel bei Beschädigung durch atmosphärische Einwirkungen zeigt. Darüber hinaus wird der Feuchtigkeitshaushalt der keratinischen Fasern stabilisiert, so dass sich die Kämmbarkeit verbessert und der Alterungsprozess verzögert wird. It has been found that the use of the combination of selected oligopeptides and methionylmethionine imparts outstanding properties to the hair treatment compositions. The hair treatment agents give the hair treated with them more resilience, which is reflected in higher tensile strengths of the keratin fibers and in a reduction of the elasticity decrease, for example, when damaged by atmospheric agents. In addition, the moisture balance of the keratinic fibers is stabilized, so that the combability improves and the aging process is delayed.
Die Haarbehandlungsmittel können weitere Wirk- und Hilfsstoffe beinhalten. Diese werden nachfolgend beschrieben. The hair treatment agents may contain other active ingredients and adjuvants. These are described below.
Vorzugsweise enthalten die Haarbehandlungsmittel zusätzlich mindestens ein Tensid, wobei oberflächenaktive Substanzen je nach Anwendungsgebiet als Tenside oder als Emulgatoren bezeichnet werden und aus anionischen, kationischen, amphoteren/zwitterionischen und nichtionischen Tensiden und Emulgatoren ausgewählt sind. Preferably, the hair treatment compositions additionally comprise at least one surfactant, surface-active substances being referred to as surfactants or as emulsifiers, depending on the field of application, and being selected from anionic, cationic, amphoteric / zwitterionic and nonionic surfactants and emulsifiers.
Bevorzugte Haarbehandlungsmittel sind dadurch gekennzeichnet, dass sie - bezogen auf sein Gewicht - 0,5 bis 70 Gew.-%, vorzugsweise 1 bis 60 Gew.-% und insbesondere 5 bis 25 Gew.-% anionische(s) und/oder nichtionische(s) und/oder kationische(s) und/oder amphotere(s)/zwitterionische(s) Tensid(e), enthalten. Preferred hair treatment agents are characterized in that they contain, based on their weight, 0.5 to 70% by weight, preferably 1 to 60% by weight and in particular 5 to 25% by weight of anionic (s) and / or nonionic ( s) and / or cationic (s) and / or amphoteric / zwitterionic surfactant (s).
Als anionische Tenside eignen sich für die Haarbehandlungsmittel alle für die Verwendung am menschlichen Körper geeigneten anionischen oberflächenaktiven Stoffe. Diese sind gekennzeichnet durch eine wasserlöslich machende, anionische Gruppe wie zum Beispiel eine Carboxylat-, Sulfat-, Sulfonat- oder Phosphat-Gruppe und eine lipophile Alkylgruppe mit etwa 8 bis 30 C-Atomen. Zusätzlich können im Molekül Glycol- oder Polyglycolether-Gruppen, Ester-, Ether- und Amidgruppen sowie Hydroxylgruppen enthalten sein. Suitable anionic surfactants for the hair treatment agents are all anionic surfactants suitable for use on the human body. These are characterized by a water-solubilizing, anionic group such as a carboxylate, sulfate, Sulfonate or phosphate group and a lipophilic alkyl group having about 8 to 30 carbon atoms. In addition, glycol or polyglycol ether groups, ester, ether and amide groups and hydroxyl groups may be present in the molecule.
Als amphotere/zwitterionische Tenside werden solche oberflächenaktiven Verbindungen bezeichnet, die im Molekül mindestens eine quartäre Ammoniumruppe und mindestens eine -COOH - oder -S03(" ' -Gruppe tragen. Besonders geeignete zwitterionische Tenside und Emulgatoren sind die sogenannten Betaine wie die N-Alkyl-N,N-dimethylammoniumglycinate, beispielsweise das Kokosalkyldimethylammoniumglycinat, N-Acyl-aminopropyl-N,N-dimethylammoniumglycinate, beispielsweise das Kokosacylaminopropyldimethylammoniumglycinat, und 2-Alkyl-3-carboxymethyl-3- hydroxyethylimidazoline mit jeweils 8 bis 18 C-Atomen in der Alkyl- oder Acylgruppe sowie das Kokosacylaminoethylhydroxyethylcarboxymethylglycinat. Ein bevorzugtes zwitterionisches Tensid ist das unter der INCI-Bezeichnung Cocamidopropyl Betaine bekannte Fettsäureamidderivat. Amphoteric / zwitterionic surfactants are surface-active compounds which contain at least one quaternary ammonium group and at least one -COOH or -SO 3 (" 'group in the molecule ## STR16 ## Particularly suitable zwitterionic surfactants and emulsifiers are the so-called betaines such as the N-alkyl group. N, N-dimethylammonium glycinates, for example cocoalkyldimethylammonium glycinate, N-acylaminopropyl N, N-dimethylammonium glycinates, for example cocoacylaminopropyldimethylammonium glycinate, and 2-alkyl-3-carboxymethyl-3-hydroxyethylimidazolines having in each case 8 to 18 C atoms in the alkyl A preferred zwitterionic surfactant is the fatty acid amide derivative known by the INCI name Cocamidopropyl Betaine.
Unter amphoteren/zwitterionischen Tensiden werden auch solche oberflächenaktiven Verbindungen verstanden, die außer einer Ce - C24 -Alkyl- oder -Acylgruppe mindestens eine freie Aminogruppe und mindestens eine -COOH- oder -SOsH-Gruppe enthalten und zur Ausbildung innerer Salze befähigt sind. Beispiele für geeignete amphotere/zwitterionische Tenside sind N-Alkylglycine, N-Alkylaminopropionsäuren, N-Alkylaminobuttersäuren, N-Alkyliminodipropionsäuren,Amphoteric / zwitterionic surfactants are also understood to mean those surface-active compounds which, apart from a Ce - C24-alkyl or -acyl group, contain at least one free amino group and at least one -COOH or -SOsH group and are capable of forming internal salts. Examples of suitable amphoteric / zwitterionic surfactants are N-alkylglycines, N-alkylaminopropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids,
N-Hydroxyethyl-N-alkylamidopropylglycine, N-Alkyltaurine, N-Alkylsarcosine, 2-N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-
Alkylaminopropionsäuren und Alkylaminoessigsäuren mit jeweils etwa 8 bis 24 C-Atomen in der Alkylgruppe. Besonders bevorzugte amphotere/zwitterionische Tenside sind das N-Kokosalkylaminopropionat, das Kokosacylaminoethylaminopropionat und das Ci2-Ci8-Acylsarcosin. Alkylaminopropionsäuren and Alkylaminoessigsäuren each having about 8 to 24 carbon atoms in the alkyl group. Particularly preferred amphoteric / zwitterionic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C 12 -C 18 -acylsarcosine.
Nichtionische Tenside und Emulgatoren enthalten als hydrophile Gruppe zum Beispiel eine Polyolgruppe, eine Polyalkylenglycolethergruppe oder eine Kombination aus Polyol- und Poly- glycolethergruppe. Nonionic surfactants and emulsifiers contain as hydrophilic group, for example, a polyol group, a polyalkylene glycol ether group or a combination of polyol and polyglycol ether group.
Ganz besonders bevorzugt sind Mittel, die zusätzlich Fettalkohol(e) und/oder Fettalkoholalkoxylat(e), vorzugsweise Ci2-22-Fettalkohol(e) und/oder Ci2-22-Fettalkoholethoxylat(e) mit 10 bis 30 EO-Einheiten, besonders bevorzugt Ci6-ie-Fettalkohol(e) und/oder Ci6-i 8-Fettalkoholethoxylat(e) mit 12 bis 20 EO- Einheiten, vorzugsweise in Mengen von 5 bis 20 Gew.-%, bevorzugt von 7,5 bis 17,5 Gew.-% und insbesondere von 10 bis 15 Gew.-%, jeweils bezogen auf das Gewicht des Haarbehandlungsmittels, enthalten. Zusammenfassend sind Haarbehandlungsmittel bevorzugt, die - bezogen auf ihr Gewicht - 0,1 bis 20 Gew.-%, vorzugsweise 0,25 bis 17,5 Gew.-% und insbesondere 5 bis 15 Gew.-% anionische(s) Tensid(e), besonders bevorzugt Fettalkoholethersulfate der Formel Very particularly preferred are agents which in addition fatty alcohol (s) and / or fatty alcohol alkoxylate (s), preferably Ci2-22 fatty alcohol (s) and / or Ci2-22 fatty alcohol ethoxylate (s) having 10 to 30 EO units, particularly preferred Ci6-he-fatty alcohol (s) and / or Ci6-i 8-fatty alcohol ethoxylate (s) having 12 to 20 EO units, preferably in amounts of 5 to 20 wt .-%, preferably from 7.5 to 17.5 wt .-% and in particular from 10 to 15 wt .-%, each based on the weight of the hair treatment agent. In summary, hair treatment compositions are preferred which, by weight, contain from 0.1 to 20% by weight, preferably from 0.25 to 17.5% by weight and in particular from 5 to 15% by weight of anionic surfactant (s ), particularly preferred fatty alcohol ether sulfates of the formula
H3C-(CH2)n-(OCH2CH2)k-OS03- M+ H 3 C- (CH 2) n (OCH 2 CH 2) k-OS03- M +
enthalten, in der n für Werte von 5 bis 21 , vorzugsweise von 7 bis 19, besonders bevorzugt von 9 bis 17 und insbesondere von 1 1 bis 13 und k für Werte von 1 , 2, 3, 4, 5, 6, 7, 8, 9 oder 10, vorzugsweise für 1 , 2 oder 3 und insbesondere für 2 stehen, und M für ein Kation aus der Gruppe Na+, K+ NH4+, Vz Mg2+, 2 Zn2+, vorzugsweise für Na+, stehen. in which n represents values of from 5 to 21, preferably from 7 to 19, particularly preferably from 9 to 17 and in particular from 1 to 13 and k for values of 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10, preferably 1, 2 or 3 and especially 2, and M is a cation from the group Na + , K + NH4 + , Vz Mg 2+ , 2Zn 2+ , preferably Na + , stand.
Als weiteren optionalen Bestandteil können die Haarbehandlungsmittel 0,01 bis 10 Gew.-% mindestens ein Polymer aus der Gruppe der kationischen und/oder amphoteren Polymere enthalten. As a further optional ingredient, the hair treatment agents may contain 0.01 to 10% by weight of at least one polymer from the group of cationic and / or amphoteric polymers.
Unter kationischen oder amphoteren Polymeren sind Polymere zu verstehen, welche in der Haupt- und/oder Seitenkette eine Gruppe aufweisen, welche "temporär" oder "permanent" kationisch sein kann. Als "permanent kationisch" werden solche Polymere bezeichnet, die unabhängig vom pH-Wert des Mittels eine kationische Gruppe aufweisen. Dies sind in der Regel Polymere, die ein quartäres Stickstoffatom, beispielsweise in Form einer Ammoniumgruppe, enthalten. Bevorzugte kationische Gruppen sind quartäre Ammoniumgruppen. Insbesondere solche Polymere, bei denen die quartäre Ammoniumgruppe über eine C1 -4-Kohlenwasserstoffgruppe an eine aus Acrylsäure, Methacrylsäure oder deren Derivaten aufgebaute Polymerhauptkette gebunden sind, haben sich als besonders geeignet erwiesen. Cationic or amphoteric polymers are to be understood as meaning polymers which have a group in the main and / or side chain which may be "temporary" or "permanent" cationic. "Permanently cationic" refers to those polymers which have a cationic group regardless of the pH of the agent. These are usually polymers containing a quaternary nitrogen atom, for example in the form of an ammonium group. Preferred cationic groups are quaternary ammonium groups. In particular, those polymers in which the quaternary ammonium group is bonded via a C1-C4 hydrocarbon group to a polymer main chain constructed from acrylic acid, methacrylic acid or derivatives thereof have proven to be particularly suitable.
Zusätzlich zu kationischen Polymerisaten oder an ihrer Stelle können die Haarbehandlungsmittel auch amphotere Polymere enthalten. Diese weisen zusätzlich zu der/den kationisch geladenen Gruppe(n) mindestens eine negativ geladene Gruppe im Molekül auf und werden auch als zwitterionische Polymere bezeichnet. In addition to cationic polymers or in their place, hair treatment agents may also contain amphoteric polymers. These have in addition to the cationically charged group (s) at least one negatively charged group in the molecule and are also referred to as zwitterionic polymers.
Vorzugsweise wird das Polymer oder werden die Polymere innerhalb engerer Mengenbereiche eingesetzt. So sind Mittel bevorzugt, die - bezogen auf ihr Gewicht - 0,05 bis 7,5 Gew.-%, vorzugsweise 0,1 bis 5 Gew.-%, besonders bevorzugt 0,2 bis 3,5 Gew.-% und insbesondere 0,25 bis 2,5 Gew.-% amphotere(s) Polymer(e), enthalten. Preferably, the polymer or polymers are used within narrower ranges. Thus, agents are preferred which - based on their weight - 0.05 to 7.5 wt .-%, preferably 0.1 to 5 wt .-%, particularly preferably 0.2 to 3.5 wt .-% and in particular From 0.25 to 2.5% by weight of amphoteric polymer (s).
Unabhängig davon, ob in den Mitteln amphotere Polymere enthalten sind oder nicht, sind weiter bevorzugte Mittel dadurch gekennzeichnet, dass sie - bezogen auf ihr Gewicht - 0,05 bis 7,5 Gew.-%, vorzugsweise 0,1 bis 5 Gew.-%, besonders bevorzugt 0,2 bis 3,5 Gew.-% und insbesondere 0,25 bis 2,5 Gew.-% kationische(s) Polymer(e), enthalten. Bevorzugte kationische Polymere sind ausgewählt aus: Regardless of whether amphoteric polymers are or are not included in the compositions, further preferred agents are characterized in that they contain, based on their weight, from 0.05 to 7.5% by weight, preferably from 0.1 to 5% by weight. %, more preferably from 0.2 to 3.5% by weight and in particular from 0.25 to 2.5% by weight of cationic polymer (s). Preferred cationic polymers are selected from:
Poly(methacryloyloxyethyltrimethylammoniumchlorid) (INCI : Polyquaternium-37) und/oder; quaternisierten Cellulose-Derivaten (INCI : Polyquaternium 10) und/oder  Poly (methacryloyloxyethyltrimethylammonium chloride) (INCI: Polyquaternium-37) and / or; quaternized cellulose derivatives (INCI: Polyquaternium 10) and / or
kationischen Alkylpolyglycosiden und/oder  cationic alkyl polyglycosides and / or
kationisertem Honig und/oder  cationised honey and / or
kationischen Guar-Derivaten und/oder  cationic guar derivatives and / or
polymeren Dimethyldiallylammoniumsalzen und deren Copolymeren mit Estern und Amiden von Acrylsäure und Methacrylsäure und/oder  polymeric dimethyldiallylammonium salts and their copolymers with esters and amides of acrylic acid and methacrylic acid and / or
Copolymeren des Vinylpyrrolidons mit quaternierten Derivaten des Dialkylaminoalkylacrylats und -methacrylats und/oder  Copolymers of vinylpyrrolidone with quaternized derivatives of dialkylaminoalkyl acrylate and methacrylate and / or
Vinylpyrrolidon-Vinylimidazoliummethochlorid-Copolymeren und/oder  Vinylpyrrolidone-Vinylimidazoliummethochlorid copolymers and / or
quaterniertem Polyvinylalkohol und/oder  quaternized polyvinyl alcohol and / or
Polyquaternium 2 und/oder  Polyquaternium 2 and / or
Polyquaternium-7 und/oder  Polyquaternium-7 and / or
Polyquaternium 17 und/oder  Polyquaternium 17 and / or
Polyquaternium 18 und/oder  Polyquaternium 18 and / or
Polyquaternium 24 und/oder  Polyquaternium 24 and / or
Polyquaternium 27 und/oder  Polyquaternium 27 and / or
Polyquaternium-101 .  Polyquaternium-101.
Eine weitere Gruppe von möglichen Inhaltsstoffen stellen die Silikone dar. Haarbehandlungsmittel enthalten das oder die Silikon(e) vorzugsweise in Mengen von 0,1 bis 10 Gew.-%, vorzugsweise von 0,25 bis 7 Gew.-% und insbesondere von 0,5 bis 5 Gew.-%, jeweils bezogen auf das gesamte Mittel. Another group of possible ingredients are the silicones. Hair treatment compositions contain the silicone (s) preferably in amounts of from 0.1 to 10% by weight, preferably from 0.25 to 7% by weight and in particular from 0, 5 to 5 wt .-%, each based on the total agent.
Weitere geeignete Inhaltsstoffe umfassen nichtionische Polymere, Fettstoffe, Wachse, Proteinhydrolysate, Aminosäuren, Vitamine, Provitamine, Vitaminvorstufen, Betaine, Biochinone, Purin(derivate), Taurin(derivate), L-Carnitin(salze), Panthenol, Panthothensäure, 2-Furanone, 2- Furanonderivate, Ectoin, Allantoin, Pflanzenextrakte, Esteröle, UV-Lichtschutzfilter, Strukturierungsmittel, Verdickungsmittel, Elektrolyte, pH-Stellmittel, Quellmittel, Farbstoffe, Antischuppenwirkstoffe, Komplexbildner, Trübungsmittel, Perlglanzmittel, Pigmente, Stabilisierungsmittel, Treibmittel, Antioxidantien, Parfümöle und/oder Konservierungsmittel. Other suitable ingredients include nonionic polymers, fatty substances, waxes, protein hydrolysates, amino acids, vitamins, provitamins, vitamin precursors, betaines, biochinones, purines (derivatives), taurine (derivatives), L-carnitine (salts), panthenol, panthothenic acid, 2-furanones, 2 furanone derivatives, ectoine, allantoin, plant extracts, ester oils, UV light stabilizers, structurants, thickeners, electrolytes, pH modifiers, swelling agents, dyes, anti-dandruff agents, chelants, opacifiers, pearlescers, pigments, stabilizers, propellants, antioxidants, perfume oils and / or preservative.
Die Haarbehandlungsmittel weisen vorteilhafte Eigenschaften auf und verleihen den mit ihnen behandelten Haaren ebenfalls vorteilhafte Eigenschaften. Insbesondere bei der Haar- und Kopfhautbehandlung wurden Vorteile beobachtet, die über die Vorteile der Oligopeptide und des Methionylmethionins alleine hinausgehen. So steigern die Haarbehandlungsmittel die Elastizität der mit ihnen behandelten Haare und führen zu einer innerstrukturellen Stärkung der Haarfasern, welche sich zum Beispiel in höheren Schmelztemperaturen bei der Differenzthermoanalyse niederschlägt. Ebenso kommt es zu einer Hydrophobierung der Haaroberfläche, die sich in einer Erhöhung des Kontaktwinkels von Wassertropfen auf der Haaroberfläche zeigt. Es zeigt sich auch eine Verbesserung der Nass- und Trockenkämmbarkeiten. The hair treatment compositions have advantageous properties and also confer advantageous properties on the hair treated with them. Especially in the hair and Scalp treatment benefits were observed beyond the benefits of oligopeptides and methionylmethionine alone. Thus, the hair treatment agents increase the elasticity of the hair treated with them and lead to an inner-structural strengthening of the hair fibers, which is reflected for example in higher melting temperatures in the differential thermal analysis. Likewise, there is a hydrophobization of the hair surface, which manifests itself in an increase in the contact angle of water droplets on the hair surface. There is also an improvement in wet and dry combabilities.
Ein weiterer Gegenstand der vorliegenden Erfindung ist entsprechend die Verwendung einer Kombination aus einem Oligopeptid, das mindestens eine Aminosäuresequenz Glu-Glu-Glu A further subject of the present invention is accordingly the use of a combination of an oligopeptide which has at least one amino acid sequence Glu-Glu-Glu
aufweist, wobei die Amino-Gruppe frei oder protoniert und die Carboxy-Gruppen frei oder deprotoniert vorliegen können, und Methionylmethionin, vorzugsweise in einem Haarbehandlungsmittel, zur Verbesserung mindestens einer der Eigenschaften  wherein the amino group may be free or protonated and the carboxy groups may be free or deprotonated, and methionylmethionine, preferably in a hair treatment agent, for improving at least one of the properties
Zugfestigkeit von keratinischen Fasern, insbesondere menschlichen Haaren; Tensile strength of keratinic fibers, especially human hair;
Stabilisierung des Feuchtigkeitshaushaltes von keratinischen Fasern, insbesondere menschlichen Haaren; Stabilizing the moisture balance of keratinic fibers, in particular human hair;
Kämmbarkeit von keratinischen Fasern, insbesondere menschlichen Haaren; Combability of keratinic fibers, in particular human hair;
Erhöhung des Kontaktwinkels zwischen Wassertropfen und der Oberfläche von keratinischen Fasern, insbesondere menschlichen Haaren; Increasing the contact angle between water droplets and the surface of keratinic fibers, in particular human hair;
Verringerung der Elastizitätsabnahme von keratinischen Fasern, insbesondere menschlichen Haaren bei Beschädigung durch atmosphärische Einwirkungen.  Reduction in elasticity of keratinic fibers, especially human hair, when damaged by atmospheric agents.
Bezüglich weiterer bevorzugter Ausführungsformen der Verwendung gilt mutatis mutandis das zu den Haarbehandlungsmitteln Gesagte. With respect to further preferred embodiments of the use mutatis mutandis applies to the hair treatment agents said.
Noch ein weiterer Gegenstand der vorliegenden Erfindung ist ein Verfahren zur Verbesserung mindestens einer der Eigenschaften Zugfestigkeit von keratinischen Fasern, insbesondere menschlichen Haaren; Stabilisierung des Feuchtigkeitshaushaltes von keratinischen Fasern, insbesondere menschlichen Haaren; Yet another object of the present invention is a method for improving at least one of the properties Tensile strength of keratinic fibers, especially human hair; Stabilizing the moisture balance of keratinic fibers, in particular human hair;
Kämmbarkeit von keratinischen Fasern, insbesondere menschlichen Haaren;  Combability of keratinic fibers, in particular human hair;
Erhöhung des Kontaktwinkels zwischen Wassertropfen und der Oberfläche von keratinischen Increasing the contact angle between water droplets and the surface of keratinic
Fasern, insbesondere menschlichen Haaren; Fibers, in particular human hair;
Verringerung der Elastizitätsabnahme von keratinischen Fasern, insbesondere menschlichen Haaren bei Beschädigung durch atmosphärische Einwirkungen  Reduction in elasticity of keratinic fibers, especially human hair, when damaged by atmospheric agents
bei dem ein Haarbehandlungsmittel, enthaltend - jeweils bezogen auf sein Gewicht - a) 0,00001 bis 20 Gew.-% mindestens eines Oligopeptids, das mindestens eine Aminosäuresequenz Glu-Glu-Glu aufweist, wobei die Amino-Gruppe frei oder protoniert und die Carboxy-Gruppen frei oder deprotoniert vorliegen können, in which a hair treatment composition containing - in each case based on its weight - a) 0.00001 to 20 wt .-% of at least one oligopeptide having at least one amino acid sequence Glu-Glu-Glu, wherein the amino group is free or protonated and the carboxy Groups may be free or deprotonated,
b) 0,0001 bis 10 Gew.-% Methionylmethionin b) 0.0001 to 10% by weight of methionylmethionine
auf die keratinischen Fasern aufgetragen, dort 5 Sekunden bis 10 Minuten belassen und dann ausgespült wird oder applied to the keratinic fibers, left there for 5 seconds to 10 minutes and then rinsed out or
auf die keratinischen Fasern aufgetragen wird und dort verbleibt. is applied to the keratinic fibers and remains there.
Bezüglich weiterer bevorzugter Ausführungsformen des Verfahrens gilt mutatis mutandis das zu den Haarbehandlungsmitteln Gesagte. With respect to further preferred embodiments of the method mutatis mutandis applies to the hair treatment agents said.
Die folgenden Beispiele sollen den Gegenstand der vorliegenden Erfindung erläutern ohne ihn jedoch zu beschränken. The following examples are intended to illustrate the subject matter of the present invention without, however, limiting it.
Beispiele Examples
Alle Mengenangaben sind, soweit nicht anders vermerkt, Gewichtsteile an Aktivstoff. Die folgenden Rezepturen wurden unter Anwendung bekannter Herstellungsverfahren bereitgestellt. All amounts are, unless otherwise stated, parts by weight of active substance. The following formulations were provided using known preparation methods.
Haarspülung: Hair conditioner:
Gew.-%  Wt .-%
Cetearyl Alcohol 5,0  Cetearyl Alcohol 5.0
Quaternium-87 0,75  Quaternium-87 0.75
Glycol Distearate 1 ,0  Glycol Distearate 1, 0
Hydrolyzed Keratin* 1 ,5 Hydrolyzed Keratin * 1, 5
Shea Butter (INCI : Butyrospermum Parkii (Shea) Butter) 1 ,5  Shea Butter (INCI: Butyrospermum Parkii (Shea) Butter) 1, 5
L-Methionyl-L-methionin 1 ,0  L-methionyl-L-methionine 1, 0
Milchsäure 0,1  Lactic acid 0.1
Behenoyl PG -Trimoniumchloride 1 ,5  Behenoyl PG -trimonium chlorides 1, 5
Behentrimonium Chloride 0,5  Behentrimonium chlorides 0.5
Polyquaternium-37 0,4  Polyquaternium-37 0.4
Glycerin 0,1  Glycerol 0.1
Dimethicone 1 ,0  Dimethicone 1, 0
Wasser, Konservierung, Begleitstoffe und ggf. Parfümöle ad 100  Water, preservation, accompanying substances and possibly perfume oils ad 100
Pflegespray: Care Spray:
Gew.-%  Wt .-%
Stearamidopropyldimethylamine 0,3  Stearamidopropyldimethylamine 0.3
Glycerin 2,0  Glycerin 2.0
Polyquaternium-10 0,2  Polyquaternium-10 0.2
Hydrolyzed Keratin* 0,1 Hydrolyzed Keratin * 0.1
Panthenol 0,2  Panthenol 0.2
DL-Methionyl-DL-methionin 0,8  DL-methionyl-DL-methionine 0.8
Ethanol 15  Ethanol 15
Nicotinsäureamid 0,1 Dicaprylyl Carbonate 0,1Nicotinic acid amide 0.1 Dicaprylyl carbonates 0.1
Cetrimonium Chloride 0,2Cetrimonium Chloride 0.2
Wasser, Konservierung, Begleitstoffe und ggf. Parfümöle ad 100 Water, preservation, accompanying substances and possibly perfume oils ad 100
Haarshampoo: Shampoo:
* enthält Oligopeptid mit der Aminosäuresequenz Glu-Glu-Glu * contains oligopeptide with the amino acid sequence Glu-Glu-Glu
s wurden die folgenden Handelsprodukte eingesetzt: s the following commercial products were used:
Handelsprodukt INCI Lieferant/Hersteller Commercial product INCI Supplier / Manufacturer
Lanette 0 Cetearyl Alcohol BASF SE Lanette 0 Cetearyl Alcohol BASF SE
Varisoft W575 PG Quaternium-87 Evonik  Varisoft W575 PG Quaternium-87 Evonik
Cutina GMS-V oder Cutina AGS Glycol Distearate BASF SE  Cutina GMS-V or Cutina AGS Glycol Distearate BASF SE
Polymer JR400 Polyquaternium-10 Dow  Polymer JR400 Polyquaternium-10 Dow
Dehyquart A CA Cetrimonium Chloride BASF SE  Dehyquart A CA Cetrimonium Chloride BASF SE
Synthalen® CR Polyquaternium-37 3V SigmaSynthalen ® CR Polyquaternium-37 3V Sigma
Quartamin BTC 131 Behenoyl PG -Trimoniumchloride Kao ChemicalsQuartamine BTC 131 Behenoyl PG Trimonium Chloride Kao Chemicals
Genamin KDMP Behentrimonium Chloride Clariant Genamin KDMP Behentrimonium Chloride Clariant
Tego Amid S 18 Stearamidopropyldimethylamine Evonik  Tego Amide S 18 Stearamidopropyldimethylamine Evonik
Ucare® Polymer JR 400 Polyquaternium-10 Dow  Ucare® Polymer JR 400 Polyquaternium-10 Dow
Cetiol CC Dicaprylyl Carbonate BASF SE  Cetiol CC dicaprylyl carbonate BASF SE
Texapon N70 NA Sodium Laureth Sulfate BASF SE  Texapon N70 NA Sodium Laureth Sulfate BASF SE
Empicol AL 70 Ammonium Lauryl Sulfate Huntsman Empicol AL 70 Ammonium Lauryl Sulfate Huntsman
Rewoteric AM 2 Disodium Cocoamphodiacetate Evonik Rewoteric AM 2 Disodium Cocoamphodiacetate Evonik
Tego Betain F50 Cocoamidopropyl Betaine Evonik  Tego Betain F50 Cocoamidopropyl Betaine Evonik
N-Hance 3196 Guar Hydroxypropyltrimonium Chloride Ashland  N-Hance 3196 Guar Hydroxypropyltrimonium Chloride Ashland

Claims

Patentansprüche: claims:
1 . Haarbehandlungsmittel, enthaltend - jeweils bezogen auf sein Gewicht - a) 0,00001 bis 20 Gew.-% mindestens eines Oligopeptids, das mindestens eine Aminosäuresequenz Glu-Glu-Glu 1 . Hair treatment compositions containing - in each case based on its weight - a) 0.00001 to 20 wt .-% of at least one oligopeptide, the at least one amino acid sequence Glu-Glu-Glu
aufweist, wobei die Amino-Gruppe frei oder protoniert und die Carboxy-Gruppen frei oder deprotoniert vorliegen können  wherein the amino group may be free or protonated and the carboxy groups may be free or deprotonated
b) 0,0001 bis 30 Gew.-% Methionylmethionin.  b) 0.0001 to 30% by weight of methionylmethionine.
Haarbehandlungsmittel nach Anspruch 1 , dadurch gekennzeichnet, dass das Oligopeptid 5 bis 15 Aminosäuren, vorzugsweise 6 bis 13 Aminosäuren, besonders bevorzugt 7 bis 12 Aminosäuren und insbesondere 8, 9 oder 10 Aminosäuren umfasst und eine Molmasse von 650 bis 3000 Da, vorzugsweise von 750 bis 2500 Da, besonders bevorzugt von 850 bis 2000 Da und insbesondere von 1000 bis 1600 Da aufweist.  Hair treatment composition according to claim 1, characterized in that the oligopeptide 5 to 15 amino acids, preferably 6 to 13 amino acids, more preferably 7 to 12 amino acids and in particular 8, 9 or 10 amino acids and a molecular weight of 650 to 3000 Da, preferably from 750 to 2500 Da, more preferably from 850 to 2000 Da and in particular from 1000 to 1600 Da.
Haarbehandlungsmittel nach einem der Ansprüche 1 oder 2, dadurch gekennzeichnet, dass das Oligopeptid Tyr-Glu-Glu-Glu-Ile  Hair treatment composition according to one of claims 1 or 2, characterized in that the oligopeptide Tyr-Glu-Glu-Glu-Ile
aufweist, wobei die Amino-Gruppe frei oder protoniert und die Carboxy-Gruppen frei oder deprotoniert vorliegen können.  wherein the amino group may be free or protonated and the carboxy groups may be free or deprotonated.
Haarbehandlungsmittel nach einem der Ansprüche 1 bis 3, dadurch gekennzeichnet, dass das Hair treatment composition according to one of claims 1 to 3, characterized in that the
aufweist, wobei die Amino-Gruppen frei oder protoniert und die Carboxy-Gruppen frei oder deprotoniert vorliegen können, wherein the amino groups are free or protonated and the carboxy groups may be free or deprotonated,
Haarbehandlungsmittel nach einem der Ansprüche 1 bis 4, dadurch gekennzeichnet, dass das Methionylmethionin eine Mischung von L-Methionyl-L-methionin, L-Methionyl-D-methionin, D- Methionyl-L-methionin und D-Methionyl-D-methionin ist.  Hair treatment composition according to one of claims 1 to 4, characterized in that the methionylmethionine is a mixture of L-methionyl-L-methionine, L-methionyl-D-methionine, D-methionyl-L-methionine and D-methionyl-D-methionine ,
Haarbehandlungsmittel nach einem der Ansprüche 1 bis 4, dadurch gekennzeichnet, dass das Methionylmethionin L-Methionyl-L-methionin und/oder D-Methionyl-D-methionin ist.  Hair treatment composition according to one of claims 1 to 4, characterized in that the methionyl methionine is L-methionyl-L-methionine and / or D-methionyl-D-methionine.
Haarbehandlungsmittel nach einem der Ansprüche 1 bis 6, dadurch gekennzeichnet, dass es - bezogen auf sein Gewicht - 0,5 bis 70 Gew.-%, vorzugsweise 1 bis 60 Gew.-%, weiter bevorzugt 2,5 bis 35 Gew.-% und insbesondere 5 bis 25 Gew.-% anionische(s) und/oder nichtionische(s) und/oder kationische(s) und/oder amphotere(s) Tensid(e), enthält. Hair treatment composition according to one of claims 1 to 6, characterized in that it - based on its weight - 0.5 to 70 wt .-%, preferably 1 to 60 wt .-%, more preferably 2.5 to 35 wt .-% and in particular from 5 to 25% by weight of anionic and / or nonionic and / or cationic and / or amphoteric surfactant (s).
Haarbehandlungsmittel nach einem der Ansprüche 1 bis 7, dadurch gekennzeichnet, dass es - bezogen auf sein Gewicht - 0,05 bis 7,5 Gew.-%, vorzugsweise 0,1 bis 5 Gew.-%, besonders bevorzugt 0,2 bis 3,5 Gew.-% und insbesondere 0,25 bis 2,5 Gew.-% kationische(s) Polymer(e), enthält, wobei bevorzugte kationische(s) Polymer(e) ausgewählt ist/sind aus  Hair treatment composition according to one of claims 1 to 7, characterized in that it - based on its weight - 0.05 to 7.5 wt .-%, preferably 0.1 to 5 wt .-%, particularly preferably 0.2 to 3 , 5 wt .-% and in particular 0.25 to 2.5 wt .-% cationic (s) polymer (s) contains, wherein preferred cationic polymer (s) is / are selected from /
Poly(methacryloyloxyethyltrimethylammoniumchlorid) (INCI : Polyquaternium-37) und/oder;  Poly (methacryloyloxyethyltrimethylammonium chloride) (INCI: Polyquaternium-37) and / or;
quaternisierten Cellulose-Derivaten (INCI : Polyquaternium 10) und/oder  quaternized cellulose derivatives (INCI: Polyquaternium 10) and / or
kationischen Alkylpolyglycosiden und/oder  cationic alkyl polyglycosides and / or
kationisertem Honig und/oder  cationised honey and / or
kationischen Guar-Derivaten und/oder  cationic guar derivatives and / or
polymeren Dimethyldiallylammoniumsalzen und deren Copolymeren mit Estern und Amiden von Acrylsäure und Methacrylsäure und/oder  polymeric dimethyldiallylammonium salts and their copolymers with esters and amides of acrylic acid and methacrylic acid and / or
Copolymeren des Vinylpyrrolidons mit quaternierten Derivaten des Dialkylamino- alkylacrylats und -methacrylats und/oder  Copolymers of vinylpyrrolidone with quaternized derivatives of dialkylaminoalkyl acrylate and methacrylate and / or
Vinylpyrrolidon-Vinylimidazoliummethochlorid-Copolymeren und/oder quatemiertem Polyvinylalkohol und/oder Vinylpyrrolidone-Vinylimidazoliummethochlorid copolymers and / or quaternized polyvinyl alcohol and / or
Polyquaternium 2 und/oder  Polyquaternium 2 and / or
Polyquaternium-7 und/oder  Polyquaternium-7 and / or
Polyquaternium 17 und/oder  Polyquaternium 17 and / or
Polyquaternium 18 und/oder  Polyquaternium 18 and / or
Polyquaternium 24 und/oder  Polyquaternium 24 and / or
Polyquaternium 27 und/oder  Polyquaternium 27 and / or
Polyquaternium-101 .  Polyquaternium-101.
9. Verfahren zur Verbesserung mindestens einer der Eigenschaften 9. A method for improving at least one of the properties
- Zugfestigkeit von keratinischen Fasern, insbesondere menschlichen Haaren;  Tensile strength of keratinic fibers, in particular human hair;
- Stabilisierung des Feuchtigkeitshaushaltes von keratinischen Fasern, insbesondere menschlichen Haaren;  Stabilization of the moisture balance of keratinic fibers, in particular human hair;
- Kämmbarkeit von keratinischen Fasern, insbesondere menschlichen Haaren;  Combability of keratinic fibers, in particular human hair;
- Erhöhung des Kontaktwinkels zwischen Wassertropfen und der Oberfläche von keratinischen Fasern, insbesondere menschlichen Haaren;  Increasing the contact angle between water droplets and the surface of keratinic fibers, in particular human hair;
- Verringerung der Elastizitätsabnahme von keratinischen Fasern, insbesondere menschlichen Haaren bei Beschädigung durch atmosphärische Einwirkungen  - Reduction in the elasticity of keratin fibers, especially human hair when damaged by atmospheric agents
dadurch gekennzeichnet, dass ein Haarhandlungsmittel, enthaltend - jeweils bezogen auf sein Gewicht - a) 0,00001 bis 20 Gew.-% mindestens eines Oligopeptids, das mindestens eine Aminosäuresequenz Glu-Glu-Glu  characterized in that a hair styling agent containing - each based on its weight - a) 0.00001 to 20 wt .-% of at least one oligopeptide, the at least one amino acid sequence Glu-Glu-Glu
aufweist, wobei die Amino-Gruppe frei oder protoniert und die Carboxy-Gruppen frei oder deprotoniert vorliegen können,  wherein the amino group may be free or protonated and the carboxy groups may be free or deprotonated,
b) 0,0001 bis 30 Gew.-% Methionylmethionin  b) 0.0001 to 30% by weight of methionylmethionine
auf die keratinischen Fasern aufgetragen, dort 5 Sekunden bis 10 Minuten belassen und dann ausgespült wird oder  applied to the keratinic fibers, left there for 5 seconds to 10 minutes and then rinsed out or
auf die keratinischen Fasern aufgetragen wird und dort verbleibt. is applied to the keratinic fibers and remains there.
10. Verwendung einer Kombination aus einem Oligopeptid, das mindestens eine Aminosäuresequenz Glu-Glu-Glu 10. Use of a combination of an oligopeptide having at least one amino acid sequence Glu-Glu-Glu
aufweist, wobei die Amino-Gruppe frei oder protoniert und die Carboxy-Gruppen frei oder deprotoniert vorliegen können, und Methionylmethionin, vorzugsweise in einem Haarbehandlungsmittel, zur Verbesserung mindestens einer der Eigenschaften  wherein the amino group may be free or protonated and the carboxy groups may be free or deprotonated, and methionylmethionine, preferably in a hair treatment agent, for improving at least one of the properties
Zugfestigkeit von keratinischen Fasern, insbesondere menschlichen Haaren;  Tensile strength of keratinic fibers, especially human hair;
Stabilisierung des Feuchtigkeitshaushaltes von keratinischen Fasern, insbesondere menschlichen Haaren;  Stabilizing the moisture balance of keratinic fibers, in particular human hair;
Kämmbarkeit von keratinischen Fasern, insbesondere menschlichen Haaren;  Combability of keratinic fibers, in particular human hair;
Erhöhung des Kontaktwinkels zwischen Wassertropfen und der Oberfläche von keratinischen Increasing the contact angle between water droplets and the surface of keratinic
Fasern, insbesondere menschlichen Haaren; Fibers, in particular human hair;
Verringerung der Elastizitätsabnahme von keratinischen Fasern, insbesondere menschlichen Haaren bei Beschädigung durch atmosphärische Einwirkungen.  Reduction in elasticity of keratinic fibers, especially human hair, when damaged by atmospheric agents.
EP15805476.7A 2014-12-09 2015-12-07 Hair treatment products containing a methionyl methionine and an oligopeptide with a glu-glu-glu sequence Withdrawn EP3229921A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102014225205.9A DE102014225205A1 (en) 2014-12-09 2014-12-09 Powerful hair treatment products with an oligopeptide and a dipeptide
PCT/EP2015/078777 WO2016091782A1 (en) 2014-12-09 2015-12-07 Hair treatment products containing a methionyl methionine and an oligopeptide with a glu-glu-glu sequence

Publications (1)

Publication Number Publication Date
EP3229921A1 true EP3229921A1 (en) 2017-10-18

Family

ID=54834821

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15805476.7A Withdrawn EP3229921A1 (en) 2014-12-09 2015-12-07 Hair treatment products containing a methionyl methionine and an oligopeptide with a glu-glu-glu sequence

Country Status (3)

Country Link
EP (1) EP3229921A1 (en)
DE (1) DE102014225205A1 (en)
WO (1) WO2016091782A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9913765D0 (en) * 1999-06-14 1999-08-11 Procter & Gamble Hair care compoaitions
BRPI0620701A2 (en) * 2005-12-16 2011-11-22 Unilever Nv composition for hair treatment
DE102007033650A1 (en) * 2007-07-17 2009-01-22 Henkel Ag & Co. Kgaa Hair treatment agent with oligopeptides
DE102008045511A1 (en) 2008-09-03 2010-03-04 Henkel Ag & Co. Kgaa Hair treatment preparations with low-dose oligopeptides

Also Published As

Publication number Publication date
DE102014225205A1 (en) 2016-06-09
WO2016091782A1 (en) 2016-06-16

Similar Documents

Publication Publication Date Title
EP2429483B1 (en) Hair care product containing acetylpyridinium salts
WO2010026010A2 (en) Hair treatment agent having low-dose oligopeptides
DE102015223832A1 (en) Powerful hair treatment with anti-washout effect
DE102015223817A1 (en) Powerful hair treatment agent with structure-strengthening effect
EP3229751A1 (en) Powerful color-protecting hair treatment agent having a dipeptide
EP1179339A2 (en) Cosmetic agent containing extracts of malvaceae seeds
WO2016139125A1 (en) Cosmetic agent with bioactive substance and a dipeptide
EP2248509A2 (en) Hair and scalp-protecting shampoos and conditioners
EP3229920B1 (en) Hair treatment compostition with methionylmethionine and a polyorganosiloxan
WO2016091785A1 (en) Cosmetic compositions with a proteolipid and methionylmethionine
DE102015223847A1 (en) Powerful hair treatment products with structurally strengthening effect
DE102015223839A1 (en) Powerful hair treatment with anti-washout effect
DE102015216690A1 (en) Powerful hair treatment agent with an oligopeptide and a magnesium salt
DE102009045856A1 (en) Cosmetic use of quaternized hydroxyethylcellulose polymers, which are substituted with cationic trimethylammonium- and dimethyldodecylammonium group, for reducing skin irritation in skin- and/or hair treatment agents
WO2016091782A1 (en) Hair treatment products containing a methionyl methionine and an oligopeptide with a glu-glu-glu sequence
WO2015048951A1 (en) Performance-enhanced hair treatment composition
DE102015216687A1 (en) "High-performance hair treatment products with a proteolipid and a magnesium salt"
DE102015212324A1 (en) "Powerful color-protective hair treatment compositions with an amino acid salt"
DE102015223816A1 (en) Powerful hair treatment agent with structure-strengthening effect
WO2022233479A1 (en) Protection of hair against environmental influence with a phenol and an organic acid
WO2022233478A1 (en) Protection of hair against environmental influence with a phenol and multivalent cations
WO2022233532A1 (en) Protection of hair structure against environmental influence with a phenol and an aminosilicone
WO2022233533A1 (en) Protection of hair structure against environmental influence, containing a phenol and an alpha-hydroxy ketone
EP2238966A2 (en) Scalp-protecting shampoos and conditioners
DE102009002883A1 (en) Scalp-friendly and scalp-soothing shampoos and conditioners

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20170509

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20180206